Cyra E Leurs

2.0k total citations
20 papers, 427 citations indexed

About

Cyra E Leurs is a scholar working on Pathology and Forensic Medicine, Oncology and Immunology. According to data from OpenAlex, Cyra E Leurs has authored 20 papers receiving a total of 427 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pathology and Forensic Medicine, 8 papers in Oncology and 6 papers in Immunology. Recurrent topics in Cyra E Leurs's work include Multiple Sclerosis Research Studies (15 papers), Polyomavirus and related diseases (7 papers) and Full-Duplex Wireless Communications (4 papers). Cyra E Leurs is often cited by papers focused on Multiple Sclerosis Research Studies (15 papers), Polyomavirus and related diseases (7 papers) and Full-Duplex Wireless Communications (4 papers). Cyra E Leurs collaborates with scholars based in Netherlands, United States and Sweden. Cyra E Leurs's co-authors include Joep Killestein, Charlotte E. Teunissen, Arjan Malekzadeh, Bernard M.J. Uitdehaag, Claire Bridel, Mike P. Wattjes, Theo Rispens, Martijn D. Steenwijk, Zoé L. E. van Kempen and Hanneke E. Hulst and has published in prestigious journals such as Neurology, Frontiers in Immunology and Nature Reviews Neurology.

In The Last Decade

Cyra E Leurs

20 papers receiving 423 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Cyra E Leurs Netherlands	13	260	123	106	77	68	20	427
Fen Bao United States	14	366 1.4×	66 0.5×	98 0.9×	53 0.7×	230 3.4×	33	565
Fariha Khalid United States	13	250 1.0×	83 0.7×	77 0.7×	20 0.3×	81 1.2×	28	395
L. Rinaldi Italy	9	496 1.9×	74 0.6×	63 0.6×	47 0.6×	215 3.2×	12	591
Makoto Hirotani Japan	14	200 0.8×	40 0.3×	121 1.1×	139 1.8×	267 3.9×	29	605
M Craner United Kingdom	4	220 0.8×	139 1.1×	97 0.9×	24 0.3×	82 1.2×	5	392
Brenda Huppke Germany	10	378 1.5×	86 0.7×	93 0.9×	64 0.8×	231 3.4×	13	516
Edoardo Galli Switzerland	11	145 0.6×	56 0.5×	96 0.9×	161 2.1×	57 0.8×	13	406
Irati Zubizarreta Spain	15	384 1.5×	40 0.3×	122 1.2×	72 0.9×	111 1.6×	23	564
Małgorzata Siger Poland	7	218 0.8×	27 0.2×	44 0.4×	68 0.9×	79 1.2×	22	403

Countries citing papers authored by Cyra E Leurs

Since Specialization

Citations

This map shows the geographic impact of Cyra E Leurs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cyra E Leurs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cyra E Leurs more than expected).

Fields of papers citing papers by Cyra E Leurs

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cyra E Leurs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cyra E Leurs. The network helps show where Cyra E Leurs may publish in the future.

Co-authorship network of co-authors of Cyra E Leurs

This figure shows the co-authorship network connecting the top 25 collaborators of Cyra E Leurs. A scholar is included among the top collaborators of Cyra E Leurs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cyra E Leurs. Cyra E Leurs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hegen, Harald, Klaus Berek, Paola Cavalla, et al.. (2023). Diagnostic value of kappa free light chain index in patients with primary progressive multiple sclerosis – a multicentre study. Frontiers in Immunology. 14. 1327947–1327947. 10 indexed citations

Broeders, Tommy A.A., Fernando A. N. Santos, Menno M. Schoonheim, et al.. (2021). Dynamic functional connectivity as a neural correlate of fatigue in multiple sclerosis. NeuroImage Clinical. 29. 102556–102556. 25 indexed citations

Leurs, Cyra E, Martijn D. Steenwijk, John J. P. Brevé, et al.. (2021). Tissue Transglutaminase Expression Associates With Progression of Multiple Sclerosis. Neurology Neuroimmunology & Neuroinflammation. 8(4). 4 indexed citations

Wieske, Luuk, Marleen J.A. Koel‐Simmelink, Madhurima Chatterjee, et al.. (2021). Serum contactin-1 as a biomarker of long-term disease progression in natalizumab-treated multiple sclerosis. Multiple Sclerosis Journal. 28(1). 102–110. 16 indexed citations

Sol, Nik, Cyra E Leurs, Eva Strijbis, et al.. (2020). Blood platelet RNA enables the detection of multiple sclerosis. Multiple Sclerosis Journal - Experimental Translational and Clinical. 6(3). 2455366752–2455366752. 12 indexed citations

Dekker, Iris, Cyra E Leurs, Marloes Hagens, et al.. (2019). Long-term disease activity and disability progression in relapsing-remitting multiple sclerosis patients on natalizumab. Multiple Sclerosis and Related Disorders. 33. 82–87. 13 indexed citations

Malekzadeh, Arjan, Cyra E Leurs, Wessel N. van Wieringen, et al.. (2019). Plasma proteome in multiple sclerosis disease progression. Annals of Clinical and Translational Neurology. 6(9). 1582–1594. 23 indexed citations

Leurs, Cyra E, Melissa A Lopes Pinheiro, Sandra den Hoedt, et al.. (2018). Acid sphingomyelinase: No potential as a biomarker for multiple sclerosis. Multiple Sclerosis and Related Disorders. 28. 44–49. 7 indexed citations

Geest, Quinten van, Linda Douw, Cyra E Leurs, et al.. (2018). Information processing speed in multiple sclerosis: Relevance of default mode network dynamics. NeuroImage Clinical. 19. 507–515. 44 indexed citations

10.

Bridel, Claire, A. J. C. Eijlers, Wessel N. van Wieringen, et al.. (2018). No Plasmatic Proteomic Signature at Clinical Disease Onset Associated With 11 Year Clinical, Cognitive and MRI Outcomes in Relapsing-Remitting Multiple Sclerosis Patients. Frontiers in Molecular Neuroscience. 11. 371–371. 2 indexed citations

11.

Kempen, Zoé L. E. van, Cyra E Leurs, Birgit I. Lissenberg‐Witte, et al.. (2017). The majority of natalizumab-treated MS patients have high natalizumab concentrations at time of re-dosing. Multiple Sclerosis Journal. 24(6). 805–810. 28 indexed citations

12.

Leurs, Cyra E, Zoé L. E. van Kempen, Iris Dekker, et al.. (2017). Switching natalizumab to fingolimod within 6 weeks reduces recurrence of disease activity in MS patients. Multiple Sclerosis Journal. 24(11). 1453–1460. 18 indexed citations

13.

Killestein, Joep, Cyra E Leurs, E.L.J. Hoogervorst, et al.. (2017). Five cases of malignant melanoma during fingolimod treatment in Dutch patients with MS. Neurology. 89(9). 970–972. 20 indexed citations

14.

Leurs, Cyra E, Petar Podlesniy, Ramón Trullás, et al.. (2017). Cerebrospinal fluid mtDNA concentration is elevated in multiple sclerosis disease and responds to treatment. Multiple Sclerosis Journal. 24(4). 472–480. 37 indexed citations

15.

Kleerekooper, Iris, Zoé L. E. van Kempen, Cyra E Leurs, et al.. (2017). Disease activity following pregnancy-related discontinuation of natalizumab in MS. Neurology Neuroimmunology & Neuroinflammation. 5(1). e424–e424. 12 indexed citations

16.

Kempen, Zoé L. E. van, Cyra E Leurs, Annick de Vries, et al.. (2017). John Cunningham virus conversion in relation to natalizumab concentration in multiple sclerosis patients. European Journal of Neurology. 24(9). 1196–1199. 8 indexed citations

17.

Vosslamber, Saskia, Sander de Ridder, John G. Wesseling, et al.. (2016). Physiological evidence for diversification of IFNα- and IFNβ-mediated response programs in different autoimmune diseases. Arthritis Research & Therapy. 18(1). 49–49. 28 indexed citations

18.

Vennegoor, Anke, Cyra E Leurs, Mike P. Wattjes, et al.. (2016). High cumulative JC virus seroconversion rate during long‐term use of natalizumab. European Journal of Neurology. 23(6). 1079–1085. 36 indexed citations

19.

Kempen, Zoé L. E. van, Cyra E Leurs, Anke Vennegoor, et al.. (2016). Natalizumab-associated progressive multifocal leukoencephalopathy is not preceded by elevated drug concentrations. Multiple Sclerosis Journal. 23(7). 995–999. 6 indexed citations

20.

Teunissen, Charlotte E., Arjan Malekzadeh, Cyra E Leurs, Claire Bridel, & Joep Killestein. (2015). Body fluid biomarkers for multiple sclerosis—the long road to clinical application. Nature Reviews Neurology. 11(10). 585–596. 78 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact